Meeting highlights from the Committee for Medicinal Products for Human Use,16-19 July 2007

Meeting highlights from the Committee for Medicinal Products for Human Use, 16-19 July 2007

Reference Number: EMEA/431407/2007

English (EN) (54.66 KB - PDF)

First published: 19/07/2007 Last updated: 19/07/2007

Questions and answers on recommendation for the refusal of the marketing authorisation for Natalizumab Elan Pharma 300 mg

Reference Number: EMEA/310856/2007

English (EN) (94.81 KB - PDF)

First published: 19/07/2007 Last updated: 19/07/2007

Questions and answers on the recommendation for the refusal of the marketing authorization for Genasense

English (EN) (40.57 KB - PDF)